Microbot Medical Inc (MBOT)

$2.42 +0.37 (18.05%)
Market Cap 138.35M
Revenue (ttm) 0.00
Net Income (ttm) -11.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 6,041,318
Avg Vol 1,828,680
Day's Range N/A - N/A
Shares Out 67.16M
Stochastic %K 37%
Beta 1.28
Analysts Strong Sell
Price Target $7.50

Company Profile

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides No...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 781 875 3605
Address:
175 Derby Street, Bld. 27, Hingham, United States
Prash83
Prash83 Feb. 24 at 6:22 PM
$MBOT those who think will get more dip here… dont miss out on the opportunity ! With more hospital news , you won’t see this level again..
0 · Reply
Loren77
Loren77 Feb. 24 at 6:05 PM
$MBOT However, we all know what the game is. An epic buyout. Every new customer brings the day of the "mother of all news" closer.
0 · Reply
Sarandon
Sarandon Feb. 24 at 6:05 PM
$MBOT 🚀🚀🚀 next .... SABR 🩳🔥 🚀🚀💯
0 · Reply
Jorlev
Jorlev Feb. 24 at 6:02 PM
$MBOT Gotta break that Dec High of $2.56
0 · Reply
Sw1ngb0t
Sw1ngb0t Feb. 24 at 5:52 PM
$MBOT nice bounce
0 · Reply
Daquanladariusblackman3
Daquanladariusblackman3 Feb. 24 at 5:48 PM
$MBOT imo this news hasn’t fully settled in. Two hospitals isn’t just proof of concept and intrigue in a novel device, it’s a precursor to major market adoption. All before the full market release.
1 · Reply
_Meowzilla1
_Meowzilla1 Feb. 24 at 5:46 PM
’@SqueezeSharkie is on a completely different level, easily ahead of 90% of traders here. If you’re serious about leveling up, you should already be following him. It’s free, takes two seconds, and you won’t regret it💎 $EJH $MBOT $AXTI $CVKD **
0 · Reply
JAAAAAY123
JAAAAAY123 Feb. 24 at 5:37 PM
$MBOT MCap 166M with groundbreaking tech. 2 major hospitals signing on, since FDA clearance. Tech not only for patients but their Docs with limited or no more exposure to radiation. The future is here. MCap Back to earth?
1 · Reply
WenABVEAudit
WenABVEAudit Feb. 24 at 5:34 PM
$MBOT I’m ready for the next leg up
1 · Reply
Logic102
Logic102 Feb. 24 at 5:15 PM
$MBOT can't fault any longs for taking some off the table today to buy back after the adrenaline junkies sell off. Just remember to buy back more shares than you sold once the price comes back to earth.
0 · Reply
Latest News on MBOT
Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System

Feb 24, 2026, 8:30 AM EST - 5 hours ago

Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System

Microbot Medical®'s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference

Feb 19, 2026, 8:30 AM EST - 5 days ago

Microbot Medical®'s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference

Microbot Medical®'s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference

Feb 12, 2026, 8:30 AM EST - 12 days ago

Microbot Medical®'s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference

Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption

Feb 5, 2026, 8:30 AM EST - 19 days ago

Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones

Jan 12, 2026, 8:30 AM EST - 6 weeks ago

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones

Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System

Nov 26, 2025, 8:30 AM EST - 3 months ago

Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

Nov 5, 2025, 8:30 AM EST - 3 months ago

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

Oct 16, 2025, 8:30 AM EDT - 4 months ago

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System

Oct 14, 2025, 8:30 AM EDT - 4 months ago

Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Oct 7, 2025, 8:00 AM EDT - 5 months ago

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

Oct 1, 2025, 9:00 AM EDT - 5 months ago

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

Sep 23, 2025, 8:30 AM EDT - 5 months ago

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Sep 16, 2025, 3:37 PM EDT - 5 months ago

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

Sep 15, 2025, 8:00 AM EDT - 5 months ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

Sep 9, 2025, 8:28 AM EDT - 6 months ago

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Sep 8, 2025, 8:28 AM EDT - 6 months ago

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst

Aug 28, 2025, 3:57 PM EDT - 6 months ago

Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Aug 20, 2025, 8:30 AM EDT - 6 months ago

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Aug 5, 2025, 8:30 AM EDT - 7 months ago

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Jul 22, 2025, 8:30 AM EDT - 7 months ago

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Jul 8, 2025, 8:30 AM EDT - 8 months ago

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Microbot Medical® Added to the Russell Microcap® Index

Jun 30, 2025, 8:30 AM EDT - 8 months ago

Microbot Medical® Added to the Russell Microcap® Index

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Jun 17, 2025, 8:30 AM EDT - 9 months ago

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Jun 9, 2025, 8:30 AM EDT - 9 months ago

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Jun 5, 2025, 8:30 AM EDT - 9 months ago

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Apr 23, 2025, 8:30 AM EDT - 10 months ago

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Apr 9, 2025, 8:30 AM EDT - 11 months ago

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Apr 1, 2025, 8:30 AM EDT - 11 months ago

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Mar 4, 2025, 8:30 AM EST - 1 year ago

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Feb 25, 2025, 8:30 AM EST - 1 year ago

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Microbot Medical Closes $13 Million Registered Direct Offering

Feb 11, 2025, 6:15 PM EST - 1 year ago

Microbot Medical Closes $13 Million Registered Direct Offering

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Feb 10, 2025, 8:00 AM EST - 1 year ago

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Closes $8.6 Million Registered Direct Offering

Jan 10, 2025, 10:25 AM EST - 1 year ago

Microbot Medical Closes $8.6 Million Registered Direct Offering

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Jan 7, 2025, 4:15 PM EST - 1 year ago

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Dec 30, 2024, 8:30 AM EST - 1 year ago

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Dec 10, 2024, 10:18 AM EST - 1 year ago

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Oct 15, 2024, 8:38 AM EDT - 1 year ago

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Sep 30, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Sep 17, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Aug 22, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Aug 13, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Aug 1, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Jul 9, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

Jul 8, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

Jul 3, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Jun 20, 2024, 8:25 AM EDT - 1 year ago

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

Jun 17, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 4, 2024, 4:20 PM EDT - 1 year ago

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 3, 2024, 12:11 PM EDT - 1 year ago

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Prash83
Prash83 Feb. 24 at 6:22 PM
$MBOT those who think will get more dip here… dont miss out on the opportunity ! With more hospital news , you won’t see this level again..
0 · Reply
Loren77
Loren77 Feb. 24 at 6:05 PM
$MBOT However, we all know what the game is. An epic buyout. Every new customer brings the day of the "mother of all news" closer.
0 · Reply
Sarandon
Sarandon Feb. 24 at 6:05 PM
$MBOT 🚀🚀🚀 next .... SABR 🩳🔥 🚀🚀💯
0 · Reply
Jorlev
Jorlev Feb. 24 at 6:02 PM
$MBOT Gotta break that Dec High of $2.56
0 · Reply
Sw1ngb0t
Sw1ngb0t Feb. 24 at 5:52 PM
$MBOT nice bounce
0 · Reply
Daquanladariusblackman3
Daquanladariusblackman3 Feb. 24 at 5:48 PM
$MBOT imo this news hasn’t fully settled in. Two hospitals isn’t just proof of concept and intrigue in a novel device, it’s a precursor to major market adoption. All before the full market release.
1 · Reply
_Meowzilla1
_Meowzilla1 Feb. 24 at 5:46 PM
’@SqueezeSharkie is on a completely different level, easily ahead of 90% of traders here. If you’re serious about leveling up, you should already be following him. It’s free, takes two seconds, and you won’t regret it💎 $EJH $MBOT $AXTI $CVKD **
0 · Reply
JAAAAAY123
JAAAAAY123 Feb. 24 at 5:37 PM
$MBOT MCap 166M with groundbreaking tech. 2 major hospitals signing on, since FDA clearance. Tech not only for patients but their Docs with limited or no more exposure to radiation. The future is here. MCap Back to earth?
1 · Reply
WenABVEAudit
WenABVEAudit Feb. 24 at 5:34 PM
$MBOT I’m ready for the next leg up
1 · Reply
Logic102
Logic102 Feb. 24 at 5:15 PM
$MBOT can't fault any longs for taking some off the table today to buy back after the adrenaline junkies sell off. Just remember to buy back more shares than you sold once the price comes back to earth.
0 · Reply
StockJelli
StockJelli Feb. 24 at 5:14 PM
Here is a momentum check for stocks ✅ be sure to check the screener to see the live updates. $LRMR $VIR $CLVT $MBOT $GRAL
0 · Reply
Freshyone
Freshyone Feb. 24 at 5:02 PM
$MBOT ~ Dip buy🔥
0 · Reply
dubovmm
dubovmm Feb. 24 at 4:52 PM
$MBOT You don't to be smart to read this: On February 24, 2026, Microbot Medical Inc. (the “Company”) issued a press release announcing that Tampa General Hospital has become the first health system in Florida to adopt the LIBERTY® Endovascular Robotic System, marking another important milestone following the Company’s recent FDA 510(k) clearance.
0 · Reply
Daquanladariusblackman3
Daquanladariusblackman3 Feb. 24 at 4:46 PM
$MBOT if those $2.13 warrants weren’t gone before they certainly are now
0 · Reply
Kazik08
Kazik08 Feb. 24 at 4:42 PM
$MBOT nice to finally see some solid action. $4 coming soon
0 · Reply
Daquanladariusblackman3
Daquanladariusblackman3 Feb. 24 at 4:41 PM
$MBOT broke that $2.50 major resistance like it was nothing, back to $3 we go
0 · Reply
Marcusjoback
Marcusjoback Feb. 24 at 4:41 PM
$MBOT ✌️
0 · Reply
Stock_Catcher
Stock_Catcher Feb. 24 at 4:38 PM
$MBOT was in youtube video beautiful move today
0 · Reply
Loren77
Loren77 Feb. 24 at 4:36 PM
$MBOT Tampa General Hospital. The First of many customers 💲💲💲
1 · Reply
stockmet
stockmet Feb. 24 at 4:35 PM
$MBOT back to $5+ soon 💎
0 · Reply
WenABVEAudit
WenABVEAudit Feb. 24 at 4:32 PM
$MBOT soon we will be seeing $5…. In the rear view mirror!!!!
0 · Reply
Freshyone
Freshyone Feb. 24 at 4:31 PM
$MBOT ~ Ka ~ BOOOOOOOMAGE Coming💥🚀🚀
0 · Reply